Los Angeles-based law firm Pierce Bainbridge Beck Price & Hecht has hired two partners to its New York office.
The Supreme Court of India has ruled that biotechnology company Monsanto’s patent for genetically modified cotton seeds is valid and enforceable in the country.
Ariosa Diagnostics, a subsidiary of Swiss healthcare firm Roche, has won a patent dispute with American biotechnology firm Illumina.
John Zurawski has joined Ballard Spahr as a partner in Philadelphia, after spending more than two years at McCarter & English.
Pfizer and Seattle-based biotech company Kineta Immuno-Oncology have signed a research and licensing agreement worth a potential $520 million.
Holland & Hart has added Rachel Carnaggio, of counsel, to its Denver office in Colorado.
ERS Genomics has signed a deal with Swiss company Lonza Pharma & Biotech to provide access to CRISPR/Cas9 technology.
France-based biotechnology company genOway has acquired the exclusive global rights to German pharmaceutical company Merck Group’s CRISPR patents, to be used in the production and sale of rodent models.
The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.
Pharmaceutical company AstraZeneca and charity Cancer Research UK have announced that they will launch a centre to accelerate the discovery of new cancer treatments.